Global Viral Conjunctivitis Drugs Supply, Demand and Key Producers, 2023-2029

Description

Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period.

This report studies the global Viral Conjunctivitis Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Viral Conjunctivitis Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Conjunctivitis Drugs that contribute to its increasing demand across many markets.

The global Viral Conjunctivitis Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The increasing investments from ophthalmic drug manufacturers for the development of efficient treatment for viral conjunctivitis, coupled with the increasing awareness among people and augmenting expenditure on healthcare, are accelerating the growth rate of this market significantly.

Highlights and key features of the study
Global Viral Conjunctivitis Drugs total market, 2018-2029, (USD Million)
Global Viral Conjunctivitis Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Viral Conjunctivitis Drugs total market, key domestic companies and share, (USD Million)
Global Viral Conjunctivitis Drugs revenue by player and market share 2018-2023, (USD Million)
Global Viral Conjunctivitis Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Viral Conjunctivitis Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Viral Conjunctivitis Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adenovir Pharma, Allergan, NanoViricides, Takeda, NovaBay Pharmaceuticals, Novartis, Panoptes Pharma and NicOx, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Conjunctivitis Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Viral Conjunctivitis Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Viral Conjunctivitis Drugs Market, Segmentation by Type
    FST-100
    APD-209

Global Viral Conjunctivitis Drugs Market, Segmentation by Application
    Hospitals
    ASCs
    Others

Companies Profiled:
    Adenovir Pharma
    Allergan
    NanoViricides
    Takeda
    NovaBay Pharmaceuticals
    Novartis
    Panoptes Pharma
    NicOx

Key Questions Answered
1. How big is the global Viral Conjunctivitis Drugs market?
2. What is the demand of the global Viral Conjunctivitis Drugs market?
3. What is the year over year growth of the global Viral Conjunctivitis Drugs market?
4. What is the total value of the global Viral Conjunctivitis Drugs market?
5. Who are the major players in the global Viral Conjunctivitis Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Viral Conjunctivitis Drugs Introduction
    1.2 World Viral Conjunctivitis Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Viral Conjunctivitis Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Viral Conjunctivitis Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Viral Conjunctivitis Drugs Market Size (2018-2029)
        1.3.3 China Viral Conjunctivitis Drugs Market Size (2018-2029)
        1.3.4 Europe Viral Conjunctivitis Drugs Market Size (2018-2029)
        1.3.5 Japan Viral Conjunctivitis Drugs Market Size (2018-2029)
        1.3.6 South Korea Viral Conjunctivitis Drugs Market Size (2018-2029)
        1.3.7 ASEAN Viral Conjunctivitis Drugs Market Size (2018-2029)
        1.3.8 India Viral Conjunctivitis Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Viral Conjunctivitis Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Viral Conjunctivitis Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.2 World Viral Conjunctivitis Drugs Consumption Value by Region
        2.2.1 World Viral Conjunctivitis Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Viral Conjunctivitis Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.4 China Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.5 Europe Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.6 Japan Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.7 South Korea Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.8 ASEAN Viral Conjunctivitis Drugs Consumption Value (2018-2029)
    2.9 India Viral Conjunctivitis Drugs Consumption Value (2018-2029)

3 World Viral Conjunctivitis Drugs Companies Competitive Analysis
    3.1 World Viral Conjunctivitis Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Viral Conjunctivitis Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Viral Conjunctivitis Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Viral Conjunctivitis Drugs in 2022
    3.3 Viral Conjunctivitis Drugs Company Evaluation Quadrant
    3.4 Viral Conjunctivitis Drugs Market: Overall Company Footprint Analysis
        3.4.1 Viral Conjunctivitis Drugs Market: Region Footprint
        3.4.2 Viral Conjunctivitis Drugs Market: Company Product Type Footprint
        3.4.3 Viral Conjunctivitis Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Viral Conjunctivitis Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Viral Conjunctivitis Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Viral Conjunctivitis Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Viral Conjunctivitis Drugs Consumption Value Comparison
        4.2.1 United States VS China: Viral Conjunctivitis Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Viral Conjunctivitis Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Viral Conjunctivitis Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Viral Conjunctivitis Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Viral Conjunctivitis Drugs Revenue, (2018-2023)
    4.4 China Based Companies Viral Conjunctivitis Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Viral Conjunctivitis Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Viral Conjunctivitis Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Viral Conjunctivitis Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Viral Conjunctivitis Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Viral Conjunctivitis Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Viral Conjunctivitis Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 FST-100
        5.2.2 APD-209
    5.3 Market Segment by Type
        5.3.1 World Viral Conjunctivitis Drugs Market Size by Type (2018-2023)
        5.3.2 World Viral Conjunctivitis Drugs Market Size by Type (2024-2029)
        5.3.3 World Viral Conjunctivitis Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Viral Conjunctivitis Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 ASCs
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Viral Conjunctivitis Drugs Market Size by Application (2018-2023)
        6.3.2 World Viral Conjunctivitis Drugs Market Size by Application (2024-2029)
        6.3.3 World Viral Conjunctivitis Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Adenovir Pharma
        7.1.1 Adenovir Pharma Details
        7.1.2 Adenovir Pharma Major Business
        7.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Product and Services
        7.1.4 Adenovir Pharma Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Adenovir Pharma Recent Developments/Updates
        7.1.6 Adenovir Pharma Competitive Strengths & Weaknesses
    7.2 Allergan
        7.2.1 Allergan Details
        7.2.2 Allergan Major Business
        7.2.3 Allergan Viral Conjunctivitis Drugs Product and Services
        7.2.4 Allergan Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Allergan Recent Developments/Updates
        7.2.6 Allergan Competitive Strengths & Weaknesses
    7.3 NanoViricides
        7.3.1 NanoViricides Details
        7.3.2 NanoViricides Major Business
        7.3.3 NanoViricides Viral Conjunctivitis Drugs Product and Services
        7.3.4 NanoViricides Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 NanoViricides Recent Developments/Updates
        7.3.6 NanoViricides Competitive Strengths & Weaknesses
    7.4 Takeda
        7.4.1 Takeda Details
        7.4.2 Takeda Major Business
        7.4.3 Takeda Viral Conjunctivitis Drugs Product and Services
        7.4.4 Takeda Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Takeda Recent Developments/Updates
        7.4.6 Takeda Competitive Strengths & Weaknesses
    7.5 NovaBay Pharmaceuticals
        7.5.1 NovaBay Pharmaceuticals Details
        7.5.2 NovaBay Pharmaceuticals Major Business
        7.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product and Services
        7.5.4 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 NovaBay Pharmaceuticals Recent Developments/Updates
        7.5.6 NovaBay Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 Novartis
        7.6.1 Novartis Details
        7.6.2 Novartis Major Business
        7.6.3 Novartis Viral Conjunctivitis Drugs Product and Services
        7.6.4 Novartis Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Novartis Recent Developments/Updates
        7.6.6 Novartis Competitive Strengths & Weaknesses
    7.7 Panoptes Pharma
        7.7.1 Panoptes Pharma Details
        7.7.2 Panoptes Pharma Major Business
        7.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Product and Services
        7.7.4 Panoptes Pharma Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Panoptes Pharma Recent Developments/Updates
        7.7.6 Panoptes Pharma Competitive Strengths & Weaknesses
    7.8 NicOx
        7.8.1 NicOx Details
        7.8.2 NicOx Major Business
        7.8.3 NicOx Viral Conjunctivitis Drugs Product and Services
        7.8.4 NicOx Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 NicOx Recent Developments/Updates
        7.8.6 NicOx Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Viral Conjunctivitis Drugs Industry Chain
    8.2 Viral Conjunctivitis Drugs Upstream Analysis
    8.3 Viral Conjunctivitis Drugs Midstream Analysis
    8.4 Viral Conjunctivitis Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Viral Conjunctivitis Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Viral Conjunctivitis Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Viral Conjunctivitis Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Viral Conjunctivitis Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Viral Conjunctivitis Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Viral Conjunctivitis Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Viral Conjunctivitis Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Viral Conjunctivitis Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Viral Conjunctivitis Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Viral Conjunctivitis Drugs Players in 2022
    Table 12. World Viral Conjunctivitis Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Viral Conjunctivitis Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Viral Conjunctivitis Drugs Player
    Table 15. Viral Conjunctivitis Drugs Market: Company Product Type Footprint
    Table 16. Viral Conjunctivitis Drugs Market: Company Product Application Footprint
    Table 17. Viral Conjunctivitis Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Viral Conjunctivitis Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Viral Conjunctivitis Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Viral Conjunctivitis Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Viral Conjunctivitis Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Viral Conjunctivitis Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Viral Conjunctivitis Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Viral Conjunctivitis Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Viral Conjunctivitis Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Viral Conjunctivitis Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Viral Conjunctivitis Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Viral Conjunctivitis Drugs Revenue Market Share (2018-2023)
    Table 29. World Viral Conjunctivitis Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Viral Conjunctivitis Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Viral Conjunctivitis Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Viral Conjunctivitis Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Viral Conjunctivitis Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Viral Conjunctivitis Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Adenovir Pharma Basic Information, Area Served and Competitors
    Table 36. Adenovir Pharma Major Business
    Table 37. Adenovir Pharma Viral Conjunctivitis Drugs Product and Services
    Table 38. Adenovir Pharma Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Adenovir Pharma Recent Developments/Updates
    Table 40. Adenovir Pharma Competitive Strengths & Weaknesses
    Table 41. Allergan Basic Information, Area Served and Competitors
    Table 42. Allergan Major Business
    Table 43. Allergan Viral Conjunctivitis Drugs Product and Services
    Table 44. Allergan Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Allergan Recent Developments/Updates
    Table 46. Allergan Competitive Strengths & Weaknesses
    Table 47. NanoViricides Basic Information, Area Served and Competitors
    Table 48. NanoViricides Major Business
    Table 49. NanoViricides Viral Conjunctivitis Drugs Product and Services
    Table 50. NanoViricides Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. NanoViricides Recent Developments/Updates
    Table 52. NanoViricides Competitive Strengths & Weaknesses
    Table 53. Takeda Basic Information, Area Served and Competitors
    Table 54. Takeda Major Business
    Table 55. Takeda Viral Conjunctivitis Drugs Product and Services
    Table 56. Takeda Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Takeda Recent Developments/Updates
    Table 58. Takeda Competitive Strengths & Weaknesses
    Table 59. NovaBay Pharmaceuticals Basic Information, Area Served and Competitors
    Table 60. NovaBay Pharmaceuticals Major Business
    Table 61. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product and Services
    Table 62. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. NovaBay Pharmaceuticals Recent Developments/Updates
    Table 64. NovaBay Pharmaceuticals Competitive Strengths & Weaknesses
    Table 65. Novartis Basic Information, Area Served and Competitors
    Table 66. Novartis Major Business
    Table 67. Novartis Viral Conjunctivitis Drugs Product and Services
    Table 68. Novartis Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Novartis Recent Developments/Updates
    Table 70. Novartis Competitive Strengths & Weaknesses
    Table 71. Panoptes Pharma Basic Information, Area Served and Competitors
    Table 72. Panoptes Pharma Major Business
    Table 73. Panoptes Pharma Viral Conjunctivitis Drugs Product and Services
    Table 74. Panoptes Pharma Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Panoptes Pharma Recent Developments/Updates
    Table 76. NicOx Basic Information, Area Served and Competitors
    Table 77. NicOx Major Business
    Table 78. NicOx Viral Conjunctivitis Drugs Product and Services
    Table 79. NicOx Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 80. Global Key Players of Viral Conjunctivitis Drugs Upstream (Raw Materials)
    Table 81. Viral Conjunctivitis Drugs Typical Customers
List of Figure
    Figure 1. Viral Conjunctivitis Drugs Picture
    Figure 2. World Viral Conjunctivitis Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Viral Conjunctivitis Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Viral Conjunctivitis Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Viral Conjunctivitis Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Viral Conjunctivitis Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Viral Conjunctivitis Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Viral Conjunctivitis Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Viral Conjunctivitis Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Viral Conjunctivitis Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Conjunctivitis Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Conjunctivitis Drugs Markets in 2022
    Figure 27. United States VS China: Viral Conjunctivitis Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Viral Conjunctivitis Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Viral Conjunctivitis Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Viral Conjunctivitis Drugs Market Size Market Share by Type in 2022
    Figure 31. FST-100
    Figure 32. APD-209
    Figure 33. World Viral Conjunctivitis Drugs Market Size Market Share by Type (2018-2029)
    Figure 34. World Viral Conjunctivitis Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Viral Conjunctivitis Drugs Market Size Market Share by Application in 2022
    Figure 36. Hospitals
    Figure 37. ASCs
    Figure 38. Others
    Figure 39. Viral Conjunctivitis Drugs Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source